兰索拉唑肠溶片联合氟哌噻吨美利曲辛治疗焦虑糜烂性胃炎患者的临床疗效研究

doi:10.3969/j.issn.1000-8535.2015.06.010

摘要/Abstract

摘要： 目的对兰索拉唑肠溶片联合氟哌噻吨美利曲辛治疗焦虑糜烂性胃炎患者的治疗效果进行研究。方法选取2013年1月—2015年1月在我院收治的伴有焦虑情绪的糜烂性胃炎患者106例。随机分为对照组,给予兰索拉唑肠溶片治疗,观察组,给予兰索拉唑肠溶片联合氟哌噻吨美利曲辛治疗,并且对疗效进行比较。结果治疗前,两组患者在腹痛、腹胀、反酸、嗳气以及黏膜糜烂各指标评分比较,差异无统计学意义(P>0.05);治疗后,2组患者以上指标均有所改善,并且观察组患者同期指标改善均优于对照组(P<0.05);治疗前,两组患者胃黏膜中PGE2和MDA含量无差异(P>0.05);治疗后,两组患者的PGE2均上升,而MDA则下降,并且观察组患者PGE2含量比对照组高,MDA则比对照组低,差异均有统计学意义(P<0.05);治疗前,两组患者HAMA、HAMD评分差异不明显,无统计学意义(P>0.05);治疗后,两组患者焦虑情况均有所改善,并且观察组患者情绪改善程度优于对照组患者,差异均有统计学意义(P<0.05);观察组不良反应发生率为5.6%,对照组不良反应发生率5.6%,差异无统计学意义,P>0.05。结论兰索拉唑与氟哌噻吨美利曲辛联合应用有助于改善糜烂性胃炎患者的病情,并且可以缓解患者的焦虑情绪,安全性高,值得临床推广。

关键词: 兰索拉唑肠溶片, 氟哌噻吨美利曲辛, 焦虑, 糜烂性胃炎

Abstract: Objective To observe the clinical efficacy of lansoprazole enteric-coated tablets combined with flupentixol-melitracen in treating anxiety patients with erosive gastritis. Methods 106 patients with erosive gastritis and anxiety in our hospital from January 2013 to January 2015 were divided into an observation group and a control group, with 53 patients in each group. The control group was given lansoprazole enteric-coated tablets alone, and the observation group was treated with lansoprazole enteric-coated tablets and flupentixol-melitracen. Clinical symptoms and mucosal erosion were compared between the two groups of patients before and after treatment. Gastric mucosa malondialdehyde (MDA) and prostration E2 (PGE2) contents, anxiety and depression status were also assessed. Results After treatment, the scores of abdominal pain, bloating, acid reflux, belching, and mucosal erosions were significantly lower in the observation group than in the control group (P< 0.05). PGE2and MDA contents in the gastric mucosa in the observation group were different from those in the control group(P< 0.05). HAMA and HAMD scores were lower in the observation group than in the control group (P< 0.05). There was no difference of adverse reaction rate between the control group and the observation group (P>0.05). Conclusion Lansoprazole enteric-coated tablets combined with flupentixol-melitracen has better clinical efficacy than lansoprazole enteric-coated tablets only in patients with erosive gastritis and anxiety in terms of the improvement of clinical symptoms and mucosal erosion and the relief of negative emotions.

Key words: Lansoprazole, Flupentixol-melitracen, Negative emotions, Erosive gastritis

苏星烽, 周运东, 廖新林. 兰索拉唑肠溶片联合氟哌噻吨美利曲辛治疗焦虑糜烂性胃炎患者的临床疗效研究[J]. 广州医药, 2015, 46(6): 33-35.

Shu Xinfeng, Zhou Yundong, Liao Xinlin. Clinical efficacy of lansoprazole enteric-coated tablets combined with flupentixol-melitracen in anxiety patients with erosive gastritis[J]. Guangzhou Medical Journal, 2015, 46(6): 33-35.

参考文献

[1] 朱祥路,陈静.焦虑抑郁障碍误诊为慢性胃炎的临床分析[J]. 医学与哲学,2014(8):80-82.
[2] Baracho NC, Ribeiro RV, Pereira RM, et al. Effects of the administration of aqueous extract of de Sedum dendroideum on the histopathology of erosive induced gastritis by means of indomethacin in rats [J]. Acta Cir Bras, 2014(29): 24-29.
[3] 支胜利,杨胜良,黄龙武,等.抑郁伴发广泛性焦虑与幽门螺杆菌感染关系的研究[J]. 全科医学临床与教育,2010,8(2):146-147,150.
[4] 潘华君.氟哌噻吨治疗伴焦虑抑郁症的浅表糜烂性胃炎的临床疗效观察[J]. 胃肠病学和肝病学杂志,2011,20(7):641-642.
[5] 邱岩.兰索拉唑联合云南红药胶囊治疗53例慢性糜烂性胃炎的疗效分析[J]. 中国医药指南,2013(31):395-395,396.
[6] 张晓彤,张丽娟,尹利顺,等.兰索拉唑联合中药治疗脾胃湿热型慢性糜烂性胃炎的临床疗效分析[J]. 中国药物评价,2014(6):366-369.
[7] 吕丽雅,周礼卿.黄芪建中汤化裁方治疗66例慢性胃炎的临床观察[J]. 广州医药,2007,38(1):69-71.
[8] Friedlander J, Shehab S, Harrison M, et al. Severe erosive hemorrhagic gastritis in a pediatric patient [J]. J Pediatr Gastroenterol Nutr,2012(55): 119.
[9] Peurad A, Hamber MM, Hunt B, et al. Helicobacter pylor-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients [J]. J Clin Gastroenterol, 2010(44):180-185.
[10] 王震,丁百静,程珍,等.氟哌噻吨美利曲辛联合胃黏膜保护剂治疗慢性胃炎症状的疗效观察[J]. 安徽医药,2013,17(8):1396-1397.
[11] 龚家顺,林嘉敏,彭惠容,等.兰索拉唑单用与兰索拉唑+氟哌噻吨美利曲辛联用治疗伴有负面情绪的糜烂性胃炎的对比研究[J]. 临床消化病杂志,2014,26(2):76-79.
[12] 谭慧珍.氟哌噻吨美利曲辛联合雷贝拉唑、莫沙必利治疗慢性胃炎临床观察[J]. 现代中西医结合杂志,2013,22(33):3727-3729.
[13] 国丽, 周宇, 叶文桃. 国产兰索拉唑结合黛力新治疗非糜烂性胃食管反流病临床观察[J].中国现代医药杂志,2008(10): 81-82.